NPPB and pulmonary arterial hypertension: The REVEAL registry illustrated four variables associated with improved survival of patients with PAH-CHD at four years from enrollment: longer 6-minute walk distance, lower mean right atrial pressure, brain natriuretic peptide level < 50 pg/mL, and the presence of acute vasoreactivity [18].